Ken Griffin Lemaitre Vascular Inc Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 3,600 shares of LMAT stock, worth $323,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,600
Previous 4,100
12.2%
Holding current value
$323,640
Previous $272,000
8.82%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding LMAT
# of Institutions
266Shares Held
20.3MCall Options Held
3.6KPut Options Held
900-
Black Rock Inc. New York, NY3.48MShares$313 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC1.94MShares$175 Million2.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.56MShares$140 Million0.0% of portfolio
-
Copeland Capital Management, LLC1.15MShares$104 Million1.81% of portfolio
-
Geneva Capital Management LLC880KShares$79.1 Million1.33% of portfolio
About LEMAITRE VASCULAR INC
- Ticker LMAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 21,962,900
- Market Cap $1.97B
- Description
- LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...